News und Analysen
EQS-News: 1&1 O-RAN: Launch of mobile services in Europe's most modern 5G network
EQS-News: 1&1 O-RAN: Launch of mobile services in Europe's most modern 5G network
EQS-News: Evotec-partner Jingxin receives approval for EVT201 in China
EQS-News: Evotec-partner Jingxin receives approval for EVT201 in China
EQS-News: Voluntary public acquisition offer to the shareholders of Telefónica Deutschland Holding AG
EQS-News: Voluntary public acquisition offer to the shareholders of Telefónica Deutschland Holding AG
EQS-Adhoc: Bechtle AG: Bechtle AG successfully places €300 million convertible bonds
EQS-Adhoc: Bechtle AG: Bechtle AG successfully places €300 million convertible bonds
EQS-Adhoc: Bechtle AG: Bechtle AG launches offering of up to €300 million convertible bonds
EQS-Adhoc: Bechtle AG: Bechtle AG launches offering of up to €300 million convertible bonds
EQS-Adhoc: CANCOM SE: Cancellation of acquired treasury shares and capital reduction
EQS-Adhoc: CANCOM SE: Cancellation of acquired treasury shares and capital reduction
EQS-News: Siltronic defines profitable growth plan until 2028
EQS-News: Siltronic defines profitable growth plan until 2028
EQS-News: CANCOM SE: CANCOM strengthens expertise in the area of complex IT infrastructure and managed services through the acquisition of significant parts of DextraData GmbH
EQS-News: CANCOM SE: CANCOM strengthens expertise in the area of complex IT infrastructure and managed services through the acquisition of significant parts of DextraData GmbH
EQS-News: 1&1 launches smartphone tariffs in its own mobile network on 8 December
EQS-News: 1&1 launches smartphone tariffs in its own mobile network on 8 December
EQS-News: MorphoSys’ Phase 3 Study of Pelabresib in Myelofibrosis Demonstrates Statistically Significant Improvement in Spleen Volume Reduction and Strong Positive Trend in Symptom Reduction
EQS-News: MorphoSys’ Phase 3 Study of Pelabresib in Myelofibrosis Demonstrates Statistically Significant Improvement in Spleen Volume Reduction and Strong Positive Trend in Symptom Reduction
EQS-Adhoc: Ad hoc: MorphoSys’ Phase 3 Study of Pelabresib in Myelofibrosis Demonstrates Statistically Significant Improvement in Spleen Volume Reduction and Strong Positive Trend in Symptom Reduction
EQS-Adhoc: Ad hoc: MorphoSys’ Phase 3 Study of Pelabresib in Myelofibrosis Demonstrates Statistically Significant Improvement in Spleen Volume Reduction and Strong Positive Trend in Symptom Reduction
EQS-News: Siltronic AG updates climate targets and joins the RE100 initiative
EQS-News: Siltronic AG updates climate targets and joins the RE100 initiative
EQS-News: MorphoSys AG Reports First Nine Months and Third Quarter 2023 Financial Results
EQS-News: MorphoSys AG Reports First Nine Months and Third Quarter 2023 Financial Results
EQS-News: Evotec presents precision medicine platforms for accelerated pipeline building at Capital Markets Day
EQS-News: Evotec presents precision medicine platforms for accelerated pipeline building at Capital Markets Day
EQS-News: Nagarro posts 12.9% YoY constant-currency revenue growth in 9M 2023
EQS-News: Nagarro posts 12.9% YoY constant-currency revenue growth in 9M 2023
EQS-News: VARTA AG achieves best quarter of the current financial year to date
EQS-News: VARTA AG achieves best quarter of the current financial year to date
EQS-Adhoc: VARTA AG: VARTA AG exceeds market expectations for the third quarter and confirms full-year guidance
EQS-Adhoc: VARTA AG: VARTA AG exceeds market expectations for the third quarter and confirms full-year guidance
EQS-News: Bechtle Continues to Record Profitable Growth in Third Quarter
EQS-News: Bechtle Continues to Record Profitable Growth in Third Quarter
EQS-News: 1&1 with good operating performance in the first 9 months of 2023
EQS-News: 1&1 with good operating performance in the first 9 months of 2023
EQS-News: United Internet with successful first nine months of 2023
EQS-News: United Internet with successful first nine months of 2023
EQS-News: Invitation to MorphoSys’ Third Quarter and First Nine Months 2023 Financial Results Conference Call on November 16, 2023
EQS-News: Invitation to MorphoSys’ Third Quarter and First Nine Months 2023 Financial Results Conference Call on November 16, 2023
EQS-News: CANCOM SE: CANCOM Group grows in a difficult economic environment thanks to successful acquisition strategy
EQS-News: CANCOM SE: CANCOM Group grows in a difficult economic environment thanks to successful acquisition strategy
EQS-News: freenet AG: freenet continues to impress with strong customer growth in IPTV and specifies 2023 guidance
EQS-News: freenet AG: freenet continues to impress with strong customer growth in IPTV and specifies 2023 guidance
EQS-News: Evotec SE reports results for the first nine months 2023 and provides corporate update
EQS-News: Evotec SE reports results for the first nine months 2023 and provides corporate update
EQS-Adhoc: Telefónica Deutschland Holding AG: Voluntary public acquisition offer by Telefónica Local Services GmbH
EQS-Adhoc: Telefónica Deutschland Holding AG: Voluntary public acquisition offer by Telefónica Local Services GmbH